Paraplegia, Spinal
12
1
1
4
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
16.7%
2 terminated out of 12 trials
66.7%
-19.8% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (12)
Transspinal Stimulation Plus Locomotor Training for SCI
Neuromodulation With Spinal Stimulation Methods
Stem Cell Spinal Cord Injury Exoskeleton and Virtual Reality Treatment Study
Stem Cells in Spinal Cord Injury
Transcutaneous and Epidural Stimulation in SCI
Activity-Dependent Transspinal Stimulation in SCI
Cardiovascular Effects of High Intensity Interval Training in Individuals With Paraplegia
Developing Strategies to Optimize the Exercise Response After Tetraplegia.
Transspinal-Transcortical Paired Stimulation for Neuroplasticity and Recovery After SCI
Transcutaneous and Epidural Spinal Stimulation for Enabling Motor Function in Humans With Motor Complete Paraplegia
Modeling, Optimization, and Control Methods for a Personalized Hybrid Walking Exoskeleton
Brain Function and White Matter Changes in Congenital, Acute and Chronic Spinal Cord Lesions